SEC Form D · filed January 8, 2024
Claris Biotherapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (21)
Kenneth C. Harrison · Jersey City, NJDirectorReza C. Dana · Jersey City, NJDirectorMarc C. De Garidel · Jersey City, NJDirectorMeredith C. Fisher · Jersey City, NJDirectorSusan Orr · Jersey City, NJExecHenry Rath · Jersey City, NJExecClarke Atwell · Jersey City, NJExec · DirectorShehzad Khan · NEW YORK, NYDirectorHenry Rath · Jersey City, NJExecLewis Teal · Vancouver, British Columbia, CanadaDirectorSusan Orr · Jersey City, NJExecTerese Gieselman · Vancouver, British Columbia, CanadaDirectorClarke Atwell · Jersey City, NJExec · DirectorVanessa Barrett · Grand Cayman, Cayman IslandsDirectorMark Floyd · Plano, TXDirectorAndrew T. Basham · Richmond, VADirectorS. T. Williams · Richmond, VADirectorSunriver Management LLC · Greenwich, CTDirectorLeslie G. Cohen · Boston, MAExec · DirectorAnthony Snow · Boca Raton, FLExecAgTech Fund IV GP, LLC · Saint Louis, MOExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗